IBSA Group

0 reviews

IBSA Group is a Swiss multinational pharmaceutical company founded in 1945 in Lugano. With a presence in over 90 countries across five continents and 20 subsidiaries, IBSA employs more than 2,300 individuals worldwide. The company specializes in ten therapeutic areas, including reproductive medicine, endocrinology, pain and inflammation, osteoarticular, aesthetic medicine, dermatology, uro-gynecology, cardiometabolic, respiratory, and consumer health. Key Features and Functionality: - Comprehensive Therapeutic Portfolio: IBSA offers a diverse range of products across multiple therapeutic areas, addressing various medical needs. - Global Reach: With operations in over 90 countries and 20 subsidiaries, IBSA ensures widespread availability of its products and services. - Research and Development: The company operates 14 Research and Development laboratories worldwide, focusing on innovative solutions in the pharmaceutical sector. - Sustainability Commitment: IBSA emphasizes sustainability, aligning its values with Environmental, Social, and Governance goals to promote well-being for people, the environment, and the community. Primary Value and User Solutions: IBSA Group's primary value lies in its dedication to enhancing global health through innovative pharmaceutical solutions. By offering a broad spectrum of products across various therapeutic areas, IBSA addresses diverse medical conditions, improving patient outcomes. Its global presence ensures that healthcare professionals and patients worldwide have access to high-quality, research-driven medications and treatments. Additionally, IBSA's commitment to sustainability reflects its responsibility towards societal well-being and environmental stewardship.